Taufon eye drops 40 mg/ml 5 ml bottle with dropper cap No. 3

Instructions Taufon eye drops 40 mg/ml 5 ml bottle with dropper cap No. 3

Composition

active ingredient: taurine;

1 ml of solution contains 40 mg of taurine;

Excipients: methyl parahydroxybenzoate (nipagin) (E 218), purified water.

Dosage form

Eye drops.

Main physicochemical properties: colorless transparent liquid.

Pharmacotherapeutic group

Means used in ophthalmology. ATX code S01X A.

Pharmacological properties

Pharmacodynamics

Taufon contains taurine - a sulfur-containing amino acid formed in the body during the conversion of cysteine. Taurine participates in the synthesis of plastic material, as a result of which it stimulates reparative and regenerative processes in dystrophic eye diseases and/or in pathological processes accompanied by a sharp disruption of the metabolism of eye tissues, including eye injuries. It contributes to the normalization of cell membrane functions, optimization of energy and metabolic processes, maintenance of the constancy of the electrolyte composition of the cytoplasm of cells, inhibition of synaptic transmission.

Pharmacokinetics

When instilled, the drug penetrates into the eye, where it exerts its specific effect. When used in therapeutic doses, taurine is practically not absorbed into the systemic bloodstream.

Indication

Dystrophic lesions of the cornea and retina, including hereditary tapetoretinal degeneration; cataracts (age-related, diabetic, traumatic, radiation); as a means of stimulating reparative processes in corneal injuries; open-angle glaucoma (as an additional agent).

Contraindication

Hypersensitivity to taurine or to other components of the drug.

Interaction with other medicinal products and other types of interactions

When used simultaneously with timolol eye drops, a potentiated decrease in intraocular and arterial pressure is observed.

When simultaneously prescribing several drugs for topical application to the eye, they should be administered at intervals of 10-15 minutes. Eye ointments should be applied last.

Application features

In open-angle glaucoma, the drug should be used in combination with timolol 20-30 minutes before instillation of timolol.

Ability to influence reaction speed when driving vehicles or other mechanisms

The effect of the drug on the human body while driving or working with other mechanisms has not been studied.

As with other topical ophthalmic drugs, temporary blurred vision or other visual disturbances may affect the ability to drive or use machines. If blurred vision occurs during instillation, the patient should wait until vision clears before driving or operating machinery.

Use during pregnancy or breastfeeding

The efficacy and safety of the drug during pregnancy or breastfeeding have not been studied.

Method of administration and doses

The drug is prescribed to adults. Immediately before use, it is advisable to hold the bottle with the drug in the palm of your hand to warm it to body temperature.

For the treatment of cataracts, prescribe 2-3 drops 2-4 times a day every day. Duration of treatment is 3 months. Repeat the course with an interval of 1 month.

For injuries, apply 2-3 drops 2-4 times a day for 1 month.

For the treatment of tapetoretinal degeneration and other degenerative diseases of the retina, penetrating corneal injuries, the drug is administered under the conjunctiva at a dose of 0.3 ml of a 4% solution once a day for 10 days. The course of treatment is repeated after 6-8 months.

In open-angle glaucoma, the drug is instilled 2-3 drops into the conjunctival sac 2 times a day 20-30 minutes before using timolol. The course of treatment is determined by the doctor individually.

Children.

The efficacy and safety of the drug in children have not been studied.

Overdose

Cases of overdose have not been described.

Adverse reactions

Some patients may develop allergic reactions, conjunctival hyperemia, itching, burning, and stinging in the eyes.

Expiration date

4 years.

The shelf life of the solution after opening the bottle is 14 days.

Storage conditions

Store at a temperature not exceeding 25 °C in the original packaging.

Keep out of reach of children.

Packaging

5 ml in bottles No. 3 with a dropper cap in a pack; 10 ml in a bottle with a dropper cap in a pack.

Vacation category

According to the recipe.

Producer

Limited Liability Company "Research Plant "GNTSLS".

Location of the manufacturer and its business address.

Ukraine, 61057, Kharkiv region, Kharkiv city, Vorobyovy street, building 8.